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ABSTRACT - Representative case summaries of patients with different types of neurogenic bladder 
diagnosed by combined cystometric-perineal electromyography and treated with bethanechol (Ure- 
choline) are presented. Determination of the activity of the periurethral striated muscle in relation to 
bladder dysfunction is extremely important in the selection of patients for bethanechol therapy. In 
the absence of structural obstruction, bethanechol can be used in patients with (1) the early phase of 
coordinated reflex neurogenic bladder and sphincter when there is incomplete bladder emptying due 
to feeble or unsustained detrusor contractions, (2) recovery phase of spinal shock when the periure- 
thral striated muscle has recovered and is under voluntary control, (3) incomplete motor paralytic 
bladder with coordinated sphincter, and (4) sensory paralytic bladder with decompensaticn. The 
bethanechol regimen will varu in accordance with the type of bladder being treated. - 
Bethanechol chloride (Urecholine)* is a parasym- 
pathomimetic agent that acts on the post- 
ganglionic parasympathetic effector cells to en- 
hance selectively the contractions of the smooth 
muscle of the gastrointestinal tract and the de- 
trusor muscle of the urinary bladder. Its clinical 
use has been described in postoperative urinary 
retention’,’ and in chronic hypotonic dysfunc- 
tion of the bladder.3 
The use of bethanechol in patients with 
neurogenic bladder is well known. It has been 
used in conjunction with intermittent catheteri- 
zation in patients with spinal cord injury to 
achieve adequate reflex voiding and a catheter- 
free state. It has also been used either at the 
onset of an intermittent catheterization program 
in all patients if no contraindications exist4,5 or 
seven to ten days later if no spontaneous voiding 
has occurred. 6 
With the advent of sophisticated instruments, 
accurate identification of the nature of the 
*hferck, Sharp and Dohme, West Point, Pennsylvania. 
neurogenic bladder dysfunction is now a reality. 
Therefore, it is possible to screen individuals 
who will benefit from bethanechol and to avoid 
indiscriminate use of this very potent and ex- 
pensive drug. 
The purpose of this report is to attempt to 
clarify the indications for the use of bethanechol 
in patients with neurogenic bladder dysfunc- 
tions. Representative case summaries will be 
presented and their significance discussed. 
Case Summaries 
Case 1 
A twenty-year-old white male was involved in 
a motorcycle accident and sustained a compres- 
sion fracture of the fourth and fifth dorsal ver- 
tebrae with a resultant complete sensory and 
motor paraplegia of the fourth dorsal vertebra. 
Ten days after the injury a combined cystomet- 
ric and perineal electromyographic study 
showed a spinal shock bladder and recovery 
phase of the periurethral striated muscle.7 Dur- 
ing the combined study, attempted voiding 
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produced no detrusor contractions or relaxation 
of the sphincter. 
The patient was placed on an intermittent 
self-catheterization program.’ One month later a 
follow-up cystometric-electromyographic study 
showed a reflex bladder with coordinated de- 
trusor and sphincter. ’ During the study, it was 
observed that the detrusor contractions were 
too weak and transient to empty the bladder 
completely in spite of complete relaxation of the 
periurethral striated muscle. Endoscopy re- 
vealed no obstruction. He was then taught vari- 
ous methods to trigger reflex voiding. In addi- 
tion, he was placed on 25 mg. of bethanechol 
orally every six hours and instructed to 
catheterize himself mainly for check of residual 
urine. He did extremely well on this program; 
his urine remained uninfected and residual 
urines were low. Bethanechol was discontinued 
without difficulty eight months after injury. 
Case 2 
Complete paraplegia of the fourth dorsal ver- 
tebra and acute urinary retention suddenly de- 
veloped in a thirty-year-old male. He was trans- 
ferred to the University of Michigan Medical 
Center and a laminectomy (third to fourth dor- 
sal vertebra) was performed; the pathology re- 
port was consistent with multiple myeloma. He 
received postoperative radiation and chemo- 
therapy but his paraplegia remained unchanged. 
A cystometric-electromyographic study one 
month after the laminectomy showed a reflex 
neurogenic bladder with an uncoordinated 
sphincter. Initial therapy consisted of intermit- 
tent self-catheterization and an anticholinergic 
agent. After more than two years of self- 
catheterization without any problem, urinary 
incontinence developed between catheteriza- 
tions. A repeat combined study showed a reflex 
neurogenic bladder with coordinated sphincter 
activity. Reflex voiding was augmented with 
bethanechol 25 mg. orally four times daily. Re- 
sidual urines were approximately 50 to 75 ml. 
after the sixth day of this regimen. Bethanechol 
was discontinued a month later when follow-up 
visits showed low residual urines. 
Case 3 
A thirty-year-old female achondroplastic 
dwarf was admitted with spastic paraparesis of 
the eighth dorsal vertebra secondary to dor- 
solumbar stenosis. A decompressive laminec- 
tomy from eighth dorsal to third lumbar vertebra 
was performed but paraparesis remained. 
A cystometric-electromyographic study two 
weeks later indicated upper and lower motor 
neuron involvement and a positive bethanechol 
test. Electromyography of the periurethral 
striated muscle revealed a spastic sphincter with 
incomplete relaxation during attempted micturi- 
tion. She was initially treated by intermittent 
self-catheterization and an anticholinergic agent. 
However, because of her stature catheterization 
was difficult and had to be terminated. 
Bethanechol, 5 mg. given subcutaneously, was 
associated with severe side effects; the dosage 
was then adjusted to 2.5 mg. subcutaneously 
every four hours. She voided small volumes 
ranging from 25 to 30 ml. and had residual 
urines of 250 to 300 ml. Bethanechol therapy 
was discontinued, and the patient was placed 
again on an indwelling Foley catheter. 
Case 4 
A twenty-six-year-old black male was shot in 
the back. Physical examination showed anes- 
thesia and analgesia on the right from the fourth 
lumbar to first sacral vertebra and anesthesia of 
the first sacral vertebra on the left. Motor 
examination revealed paralysis of the right lower 
extremity from the fourth lumbar vertebra. 
Combined cystometry and electromyography 
showed an incomplete motor paralytic bladder 
with partial denervation of the periurethral 
striated muscle. During this combined study, it 
was demonstrated that attempted voiding pro- 
duced no voiding contractions but resulted in 
relaxation of the periurethral striated muscle. 
Bethanechol (7.5 mg. subcutaneously every six 
hours) was given, and the patient voided spon- 
taneously with residual urines in the 30- to 
lOO-ml. range. Bethanechol was reduced to 5 
mg. subcutaneously every six hours three days 
later. The residual urine remained low on this 
dosage, and after two days bethanechol was 
changed to 50 mg. orally every six hours. The 
patient continued to void adequately with low 
residuals of 35 to 40 ml., and the bethanechol 
was discontinued after several more days. 
Case 5 
A nineteen-year-old white male suffered a 
flexion injury to his cervical spine with a result- 
ant dislocation at the fourth to fifth cervical ver- 
tebra. He underwent a laminectomy on May 6, 
1975. On June 3, 1975, the patient was trans- 
ferred to the University of Michigan Medical 
Center, and physical examination at that time 
showed fair to good muscle strength in all 
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extremities, clonus in lower extremities, and 
bilateral Hoffmann and Babinski signs. Cys- 
tometrograms and electromyograms showed a 
spinal shock bladder with recovery phase of the 
striated musculature. The periurethral striated 
muscle showed increasing electrical activity 
with bladder distention. Attempts at voiding 
produced voluntary relaxation of the striated 
muscle without any noticeable change in the in- 
travesical pressure. He was treated with 
bethanechol 2.5 mg. subcutaneously every four 
hours. With this dosage abdominal cramps de- 
veloped, and the dose was then reduced to 25 
mg. orally every six hours. He urinated with 
high residual urines, and after a week the 
bethanechol dosage was increased to 50 mg. or- 
ally every six hours. He responded well to this 
dose and voided with volumes of 300 ml. and 
residual urines of 40 to 50 ml. Bethanechol was 
discontinued one month later; residual urines 
were 50 to 70 ml., and voided volumes were 
300 to 350 ml. 
Comment 
Normal micturition is a complex process 
which requires integration of a central neuronal 
network with a peripheral neuromuscular sys- 
tem. The end result is a voluntary coordinated 
detrusor contraction and periurethral striated 
muscle relaxation. The central neuronal net- 
work, responsible for the volitional control, con- 
sists of pathways between the white and gray 
matter of the frontal lobes, specific thalamic 
nuclei, basal ganglia, and the cerebellum to the 
second to fourth sacral segments. The 
peripheral neuromuscular component consists of 
a reflex arc involving the second to fourth sacral 
segments with motor axons to the detrusor pass- 
ing via the pelvic nerve, and motor axons to the 
periurethral striated musculature passing via the 
pudendal nerve. 
A lesion of any of the neurologic components 
of this reflex may result in vesical dysfunction, a 
condition which is called neurogenic bladder.’ 
After the initial insult to the spinal cord, a 
majority of the patients go through a period of 
spinal shock, when all neural reflexes below the 
level of the injury are absent. The return of 
reflex activity varies in both time and type; 
striated muscle activity usually recovers earlier 
than smooth muscle activity. 7 
Spinal shock can be divided into two phases, 
acute and recovery. During the acute phase the 
bladder exhibits no contractions and the peri- 
urethral striated muscle no electrical activity. 
During this acute phase, bethanechol is ineffec- 
tive. In the recovery phase of spinal shock, the 
bladder is still inactive, but now the periure- 
thral striated muscle will reveal varying degrees 
of electrical activity. 
In incomplete lesions of the spinal cord above 
the sacral reflex arc, voluntary relaxation of the 
periurethral striated muscle can occur without 
detrusor contraction and may be elicited by ask- 
ing the patient to attempt voiding. This indi- 
cates that voluntary somatic control to the 
sphincter has recovere’d or is in the recovery 
phase. We have found bethanechol extremely 
helpful in rehabilitating this type of bladder 
(Case 5). The dose starts with 2.5 to 5 mg. of 
bethanechol subcutaneously every four to six 
hours with catheterization for residuals once or 
twice a day. When residual urine is less than 50 
ml., the dose is converted to either 2.5 mg. 
subcutaneously or directly to 50 mg. orally 
every six hours. After a minimum period of one 
week, the dose is tapered and ultimately discon- 
tinued if residual urine remains low. Not in- 
frequently it may be necessary to administer the 
oral bethanechol for a number of weeks or 
months before satisfactory voiding is attained 
and the drug can be discontinued. 
In patients with complete spinal cord lesion 
above the second to fourth sacral segments, an 
involuntary micturition reflex will appear weeks 
or months after the injury. The combined 
cystometric-electromyographic study has shown 
two types of reflex neurogenic bladders, co- 
ordinated and uncoordinated detrusor and 
sphincter. The uncoordinated type is obviously 
not suited for bethanechol and reflex voiding 
because of the functional obstruction created by 
the contraction of the striated musculature dur- 
ing detrusor contraction (Case 3). The bladder 
with coordinated detrusor and sphincter is ideal 
for reflex voiding. We have used bethanechol in 
the early phase of the trial voiding if during the 
combined study the detrusor contractions are 
weak (low amplitude) or not sustained (Cases 1 
and 2), leading to incomplete bladder emptying. 
Endoscopy should be performed to rule out out- 
let obstruction. 
Because paraplegic patients are supersensi- 
tive to bethanechol, smaller oral doses are usu- 
ally effective in producing stronger detrusor 
contractions. An initial dose of 25 mg. orally 
every six hours is used, and the dosage is in- 
creased or reduced depending on the response 
of the individual. Once reflex voiding is fully es- 
tablished the drug is withdrawn, and the patient 
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is examined periodically to be certain that fre- 
quent complete bladder emptying is main- 
tained. 
Injuries involving sacral segments two to four 
or the pelvic nerve may produce either a com- 
plete or incomplete lower motor neuron blad- 
der. The patients with complete motor paralytic 
bladder and autonomous neurogenic bladder are 
not suitable for bethanechol therapy because 
they are either totally incontinent from absence 
of sphincter control or lack the necessary coor- 
dination between the detrusor and sphincter. 
Patients with incomplete lesions may be candi- 
dates for bethanechol therapy if the partial 
motor paralytic bladder is associated with relax- 
ation of the periurethral striated muscle during 
attempts at voiding. In this situation incomplete 
bladder emptying can be improved by 
bethanechol (Case 4). In cases of absent or very 
weak voluntary detrusor contractions, we have 
utilized higher doses of bethanechol as recom- 
mended by Lapides lo to rehabilitate the blad- 
der. An inital dose of 7.5 to 10 mg. subcutane- 
ously every four to six hours in adults was found 
necessary to effect adequate emptying. The 
dose is then tapered every three days, 2.5 mg. 
at a time, to a minimum dose of 5 mg. sub- 
cutaneously every four to six hours. After three 
days and residual urines of less than 50 ml. the 
dosage is changed to 50 mg. orally every six 
hours. The patients are maintained on this dos- 
age if attempts to reduce it are unsuccessful. 
The decompensated bladders observed in pa- 
tients with sensory paralytic bladder are man- 
aged in the same manner as the incomplete 
motor paralytic bladders. In this condition the 
problem is the inability of the detrusor to pro- 
duce effective contraction to empty the bladder 
despite the periurethral striated muscle relaxing 
during the attempted voiding. The success of 
bethanechol therapy will depend on the extent 
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